Iridex (NASDAQ: IRIX) owner adds 266,068 shares in late SEC filing

What happened

Iridex Corp (NASDAQ: IRIX) said 10% owner Shih-Yao David Lin bought 266,068 shares indirectly through Xinpo at $0.88 to $1.52. The purchases ran from 2025-06-06 to 2025-12-01 and totaled about $273,611. The Rule 10b5-1 box is unchecked.

The form lists 30 open-market purchase lines. After the last purchase, Lin held 836,252 shares through Xinpo. The filing also says Lin beneficially owned 1,738,238 shares in aggregate, including 1,186,809 through Xinpo and 551,429 through Novel Inspiration. This Form 4 says it is the second of three filings and was filed late.

Key numbers

Metric	Latest	Change	Source
Shares bought	266,068 shares		SEC Form 4
Price per share	$0.88 to $1.52		SEC Form 4
Total purchase value	about $273,611		SEC Form 4
Shares held after purchase	836,252 shares		SEC Form 4
Purchase as share of prior holding	46.7%		Calculated from SEC Form 4

Read more: Iridex (IRIX) stock analysis and investment case

Why it matters

OptimistFi's case is that Iridex is investable only as a fragile ophthalmic-laser turnaround, so sustained insider accumulation matters. The reported 266,068 shares equal about 46.7% of the 570,184 shares held before this batch, which is a large add-on to the position.

The price range also shows the buying continued at different levels, from $0.88 to $1.52 a share. The buys were spread across June, July, October, November and December, which makes this look like a multi-month accumulation instead of a single print. That matters because the filing shows repeated open-market buying, not one isolated transaction.

The form also says the purchases were previously unreported open-market purchases from 2025-03-25 through 2026-03-30, which puts this batch in a broader sequence rather than a one-off event.

A one-day trade would matter less than a pattern that kept building into December. The caveat is that the purchases were indirect through Xinpo and the filing was late, so the disclosure is backward-looking.

Browse: stock research on every company OptimistFi covers

What's next

The remarks say this is the second of three Form 4 filings for previously unreported open-market purchases from 2025-03-25 through 2026-03-30. The next filing in that sequence is the clearest follow-up test for whether the accumulation kept going.

More buying in that third Form 4 would strengthen the case. A lighter follow-up would leave this report as a snapshot of past purchases rather than a fresh signal.

More from OptimistFi